225 related articles for article (PubMed ID: 15389565)
1. Ectodomain shedding of membrane-anchored heparin-binding EGF like growth factor and subcellular localization of the C-terminal fragment in the cell cycle.
Toki F; Nanba D; Matsuura N; Higashiyama S
J Cell Physiol; 2005 Mar; 202(3):839-48. PubMed ID: 15389565
[TBL] [Abstract][Full Text] [Related]
2. Roles of charged amino acid residues in the cytoplasmic domain of proHB-EGF.
Nanba D; Toki F; Higashiyama S
Biochem Biophys Res Commun; 2004 Jul; 320(2):376-82. PubMed ID: 15219838
[TBL] [Abstract][Full Text] [Related]
3. An intermediary role of proHB-EGF shedding in growth factor-induced c-Myc gene expression.
Nanba D; Inoue H; Shigemi Y; Shirakata Y; Hashimoto K; Higashiyama S
J Cell Physiol; 2008 Feb; 214(2):465-73. PubMed ID: 17674363
[TBL] [Abstract][Full Text] [Related]
4. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export of PLZF.
Nanba D; Mammoto A; Hashimoto K; Higashiyama S
J Cell Biol; 2003 Nov; 163(3):489-502. PubMed ID: 14597771
[TBL] [Abstract][Full Text] [Related]
6. A nuclear form of the heparin-binding epidermal growth factor-like growth factor precursor is a feature of aggressive transitional cell carcinoma.
Adam RM; Danciu T; McLellan DL; Borer JG; Lin J; Zurakowski D; Weinstein MH; Rajjayabun PH; Mellon JK; Freeman MR
Cancer Res; 2003 Jan; 63(2):484-90. PubMed ID: 12543806
[TBL] [Abstract][Full Text] [Related]
7. Spatiotemporal visualization of proHB-EGF ectodomain shedding in living cells.
Inoue H; Sakaue T; Ozawa T; Higashiyama S
J Biochem; 2013 Jul; 154(1):67-76. PubMed ID: 23598347
[TBL] [Abstract][Full Text] [Related]
8. Possible role of coexpression of CD9 with membrane-anchored heparin-binding EGF-like growth factor and amphiregulin in cultured human keratinocyte growth.
Inui S; Higashiyama S; Hashimoto K; Higashiyama M; Yoshikawa K; Taniguchi N
J Cell Physiol; 1997 Jun; 171(3):291-8. PubMed ID: 9180898
[TBL] [Abstract][Full Text] [Related]
9. Identification of serum factor inducing ectodomain shedding of proHB-EGF and sStudies of noncleavable mutants of proHB-EGF.
Hirata M; Umata T; Takahashi T; Ohnuma M; Miura Y; Iwamoto R; Mekada E
Biochem Biophys Res Commun; 2001 May; 283(4):915-22. PubMed ID: 11350072
[TBL] [Abstract][Full Text] [Related]
10. The chemical synthesis and binding affinity to the EGF receptor of the EGF-like domain of heparin-binding EGF-like growth factor (HB-EGF).
Shin SY; Yokoyama T; Takenouchi T; Munekata E
J Pept Sci; 2003 Apr; 9(4):244-50. PubMed ID: 12725245
[TBL] [Abstract][Full Text] [Related]
11. Membrane-associated HB-EGF modulates HGF-induced cellular responses in MDCK cells.
Singh AB; Tsukada T; Zent R; Harris RC
J Cell Sci; 2004 Mar; 117(Pt 8):1365-79. PubMed ID: 14996914
[TBL] [Abstract][Full Text] [Related]
12. An oxidative stress mechanism mediates chelerythrine-induced heparin-binding EGF-like growth factor ectodomain shedding.
Kim J; Lin J; Adam RM; Lamb C; Shively SB; Freeman MR
J Cell Biochem; 2005 Jan; 94(1):39-49. PubMed ID: 15490481
[TBL] [Abstract][Full Text] [Related]
13. Transactivation of epidermal growth factor receptor after heparin-binding epidermal growth factor-like growth factor shedding in the migration of prostate cancer cells promoted by bombesin.
Madarame J; Higashiyama S; Kiyota H; Madachi A; Toki F; Shimomura T; Tani N; Oishi Y; Matsuura N
Prostate; 2003 Nov; 57(3):187-95. PubMed ID: 14518027
[TBL] [Abstract][Full Text] [Related]
14. Activity-dependent shedding of heparin-binding EGF-like growth factor in brain neurons.
Shishido Y; Tanaka T; Piao YS; Araki K; Takei N; Higashiyama S; Nawa H
Biochem Biophys Res Commun; 2006 Sep; 348(3):963-70. PubMed ID: 16901467
[TBL] [Abstract][Full Text] [Related]
15. Suppression of proHB-EGF carboxy-terminal fragment nuclear translocation: a new molecular target therapy for gastric cancer.
Shimura T; Kataoka H; Ogasawara N; Kubota E; Sasaki M; Tanida S; Joh T
Clin Cancer Res; 2008 Jun; 14(12):3956-65. PubMed ID: 18559618
[TBL] [Abstract][Full Text] [Related]
16. Anti-human HB-EGF monoclonal antibodies inhibiting ectodomain shedding of HB-EGF and diphtheria toxin binding.
Hamaoka M; Chinen I; Murata T; Takashima S; Iwamoto R; Mekada E
J Biochem; 2010 Jul; 148(1):55-69. PubMed ID: 20332144
[TBL] [Abstract][Full Text] [Related]
17. Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors.
Sanderson MP; Dempsey PJ; Dunbar AJ
Growth Factors; 2006 Jun; 24(2):121-36. PubMed ID: 16801132
[TBL] [Abstract][Full Text] [Related]
18. Hamster diphtheria toxin receptor: a naturally occurring chimera of monkey and mouse HB-EGF precursors.
Cha JH; Brooke JS; Eidels L
Biochem Biophys Res Commun; 1999 Jan; 254(2):325-9. PubMed ID: 9918837
[TBL] [Abstract][Full Text] [Related]
19. Membrane-anchored growth factors, the epidermal growth factor family: beyond receptor ligands.
Higashiyama S; Iwabuki H; Morimoto C; Hieda M; Inoue H; Matsushita N
Cancer Sci; 2008 Feb; 99(2):214-20. PubMed ID: 18271917
[TBL] [Abstract][Full Text] [Related]
20. Ectodomain shedding of HB-EGF: a potential target for cancer therapy.
Miyazono K
J Biochem; 2012 Jan; 151(1):1-3. PubMed ID: 21976708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
